See the DrugPatentWatch profile for Prasugrel
What is prasugrel used for?
Prasugrel (brand: Effient) is an antiplatelet medicine used to help prevent blood clots in people with acute coronary syndrome who are treated with a procedure to open blocked heart arteries, such as PCI (percutaneous coronary intervention/stent placement). It works by blocking platelet activation through the P2Y12 ADP receptor, which reduces the risk of thrombotic events.
Which patients are typically prescribed prasugrel?
In routine clinical use, prasugrel is prescribed for adults with acute coronary syndrome (for example, unstable angina, NSTEMI, or STEMI) when they undergo PCI. It is taken alongside other antiplatelet therapy (most commonly aspirin) to lower the risk of heart attack and stent-related clotting.
How is prasugrel usually taken (and what medicines is it paired with)?
Prasugrel is taken by mouth as an antiplatelet agent and is used in combination with aspirin as part of dual antiplatelet therapy. The exact dosing schedule depends on the patient’s situation and the clinician’s plan.
When might prasugrel not be used?
Prasugrel is often avoided or used cautiously in certain situations because antiplatelet therapy increases bleeding risk. Common examples that clinicians consider include a history of stroke or transient ischemic attack (TIA) and other high-bleeding-risk conditions.
What side effects do patients ask about?
The main expected risk is bleeding (easy bruising, nosebleeds, gastrointestinal bleeding, or more serious bleeding). Patients are also typically told to seek urgent care for signs of serious bleeding.
How does prasugrel differ from clopidogrel or ticagrelor?
All three are antiplatelet drugs used in acute coronary syndrome, but they differ in drug class characteristics (prasugrel and clopidogrel are P2Y12 inhibitors; ticagrelor is also a P2Y12 inhibitor but with different properties). Choice among them depends on bleeding risk, prior medical history, and guideline/label fit for the patient.
Sources
No provided sources mentioned for prasugrel’s labeled indications in the material available here. If you share the source text or label excerpt you’re working from, I can tailor the answer to match it exactly.